Contents
Current Pharmaceutical Design, Volume 10 - Number 4
Update on Sirolimus Drug-Eluting Stents
, 10(4): 337 - 348Nicholas Kipshidze, Martin B. Leon, Mykola Tsapenko, Robert Falotico, Gregory A. Kopia and Jeffrey Moses
DOI: 10.2174/1381612043453315
Dexamethasone and Restenosis After Coronary Stent Implantation: New Indication for an Old Drug?
, 10(4): 349 - 355Peter W. Radke, Christian Weber, Axel Kaiser, Andreas Schober and Rainer Hoffmann
DOI: 10.2174/1381612043453324
Local Drug Delivery Using Coated Stents: New Developments and Future Perspectives
, 10(4): 357 - 367Kengo Tanabe, Evelyn Regar, Chi Hang Lee, Angela Hoye, Willem J. van der Giessen and Patrick W. Serruys
DOI: 10.2174/1381612043453289
GP IIb / IIIa Blockade in Elective Percutaneous Coronary Intervention
, 10(4): 387 - 398Dery J.P., Harrington R.A. and Tcheng J.E.
DOI: 10.2174/1381612043453306
Adjunctive Therapy for Percutaneous Revascularization in Acute Myocardial Infarction
, 10(4): 399 - 405Sorin J. Brener and Eric J. Topol
DOI: 10.2174/1381612043453333
Gene Therapy for Cardiovascular Diseases
, 10(4): 407 - 423Marcin Gruchala, Himadri Roy, Shalini Bhardwaj and Seppo Yla-Herttuala
DOI: 10.2174/1381612043453379
Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
, 10(4): 425 - 432Claudio Napoli and Vincenzo Sica
DOI: 10.2174/1381612043453388
Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
, 10(4): 433 - 448Enrico Garattini, Maurizio Gianni and Mineko Terao
DOI: 10.2174/1381612043453351
Webmaster Contact: info@benthamscience.net